The effects of diet and orlistat on body weight and lipid profiles in high risk Chinese patients with coronary artery disease, obesity and hypercholesterolemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11845-009-0291-y.pdf
Reference20 articles.
1. Woo KS, Donnan SPB (1989) Epidemiology of coronary arterial disease in the Chinese. Intern J Card 24:83–93. doi: 10.1016/0167-5273(89)90045-4
2. Department of Health, Government of the Hong Kong Special Administrative Region (2004). Department of Health Annual Report 2003/2004:34
3. Janus ED, Postiglione A, Singh RB, Lewis B (1996) The modernization of Asia: implications for coronary heart disease. Circulation 94:2671–2673
4. Montaye M, De Bacquer D, De Backer G, Amouyel P (2000) Overweight and obesity: a major challenge for coronary heart disease secondary prevention in clinical practice in Europe. Eur Heart J 21:808–813. doi: 10.1053/euhj.1999.1854
5. Zavoral JH (1998) Treatment with orlistat reduces cardiovascular risk in obese patients. J Hypertens 16:2013–2017. doi: 10.1097/00004872-199816121-00024
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current trends and future prospects of lipstatin: a lipase inhibitor and pro-drug for obesity;RSC Advances;2015
2. Orlistat improves endothelial function in obese adolescents: A randomised trial;Journal of Paediatrics and Child Health;2013-06-05
3. Lapacho Tea(Tabebuia impetiginosa)Extract Inhibits Pancreatic Lipase and Delays Postprandial Triglyceride Increase in Rats;Phytotherapy Research;2012-03-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3